Tag: Cancer: Breast
Prediction Model for Invasive Breast Cancer Improved With Additional Risk Factors
Body mass index was associated with largest improvement in estimated risk for individual women
ASTRO Issues Guidance Related to Partial Breast Irradiation
Daily or every-other-day external beam PBI regimen preferred over twice-daily regimen due to late toxicity concerns
Neratinib, Fulvestrant, Trastuzumab Combo Aids Metastatic Breast Cancer
Three-drug combination beneficial for HR-positive HER2-mutant metastatic breast cancer with prior CDK4/6i therapy
Mortality Higher for Black Patients Receiving Neoadjuvant Chemo for Breast Cancer
Black patients have increased mortality in refractory, sensitive disease; Asians have lower risk in refractory, sensitive, very sensitive disease
Overall Survival Benefit Up for Pyrotinib + Capecitabine in HER2-Positive Breast Cancer
Overall survival benefit demonstrated among patients with metastatic breast cancer who had received trastuzumab and taxanes
Risk for Breast Cancer Examined After False-Positive Mammogram
Higher hazard ratios seen for women aged 60 to 75 years at examination, with lower mammographic breast density
Women May Not Recognize Non-Lump Symptoms of Breast Cancer
Fewer than half of survey respondents could identify lesser-known symptoms
Breast Satisfaction Increased for Women Undergoing Autologous Reconstruction
Higher levels of breast satisfaction and psychosocial and sexual well-being reported compared with alloplastic breast reconstruction
ASTRO: Hypofractionation Effective for Radiotherapy After Breast Reconstruction
Use of hypofractionation is as effective as conventionally fractionated RT for women undergoing reconstruction after mastectomy
Subsequent Breast Cancer Risk Higher for Child Cancer Survivors Receiving Doxorubicin
More than twofold increase in risk seen for those treated with ≥200 mg/m² cumulative doxorubicin versus no doxorubicin
